Presentation: Key Considerations for Pharma Developing a Digital Therapeutic

This video features Biofourmis Chief Operating Officer Jaydev Thakkar’s presentation at DTx West 2022, covering Key Considerations for Pharma Developing a Digital Therapeutic.

Biofourmis is pioneering a new category of medicine by developing clinically-validated, software-based therapeutics to treat and manage patients with unmet clinical needs. These digital therapeutics work independently or in conjunction with pharmacotherapies – augmenting drug efficacy, reducing costs and driving better patient outcomes.

Pharmaceutical companies prescribe digital therapeutics as a companion therapy with high-value drugs to improve efficacy and to better manage and treat patients with complex chronic conditions.